Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Sep 4;83(7):887–891. doi: 10.1054/bjoc.2000.1396

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues

K Akagi 1, Y Ikeda 1, M Miyazaki 1, T Abe 1, J Kinoshita 1, Y Maehara 1, K Sugimachi 1
PMCID: PMC2374684  PMID: 10970690

Abstract

Vascular endothelial growth factor-C (VEGF-C) functions specifically to induce lymphangiogenesis. We examined the relationship between expression of VEGF-C and clinicopathological features in patients with colorectal cancer. The expression of VEGF-C in the 99 primary tumours and 18 metastatic lymph nodes from colorectal cancer patients was examined immunohistochemically. To verify VEGF-C mRNA expression, reverse transcriptase-polymerase chain reaction (RT-PCR) was carried out. The expression of VEGF-C correlated with lymphatic involvement, lymph nodes metastasis, and depth of invasion. On the other hand, correlations were nil with regard to gender of the patients, histologic type, venous involvement, and liver metastasis. The expression of VEGF-C in metastatic lymph nodes was fairly consistent with this expression in the primary tumour. Survival time was shorter for VEGF-C positive groups than for VEGF-C negative ones, but with no statistically significant difference. RT-PCR findings revealed that the expression of VEGF-C mRNA correlated mostly with that of VEGF-C protein expression. VEGF-C may play an important role in lymphatic spread of colorectal cancer. © 2000 Cancer Research Campaign

Keywords: VEGF-C, lymphatic involvement, lymph nodes metastasis, colorectal carcinoma

Full Text

The Full Text of this article is available as a PDF (379.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapuis P. H., Dent O. F., Fisher R., Newland R. C., Pheils M. T., Smyth E., Colquhoun K. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg. 1985 Sep;72(9):698–702. doi: 10.1002/bjs.1800720909. [DOI] [PubMed] [Google Scholar]
  2. DUKES C. E., BUSSEY H. J. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958 Sep;12(3):309–320. doi: 10.1038/bjc.1958.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997 Feb;18(1):4–25. doi: 10.1210/edrv.18.1.0287. [DOI] [PubMed] [Google Scholar]
  4. Fielding L. P., Phillips R. K., Fry J. S., Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet. 1986 Oct 18;2(8512):904–907. doi: 10.1016/s0140-6736(86)90422-8. [DOI] [PubMed] [Google Scholar]
  5. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg. 1995 Mar-Apr;19(2):184–190. doi: 10.1007/BF00308624. [DOI] [PubMed] [Google Scholar]
  6. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R. K., Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997 May 30;276(5317):1423–1425. doi: 10.1126/science.276.5317.1423. [DOI] [PubMed] [Google Scholar]
  7. Joukov V., Kaipainen A., Jeltsch M., Pajusola K., Olofsson B., Kumar V., Eriksson U., Alitalo K. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol. 1997 Nov;173(2):211–215. doi: 10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  8. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996 Apr 1;15(7):1751–1751. [PMC free article] [PubMed] [Google Scholar]
  9. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V. W., Fang G. H., Dumont D., Breitman M., Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566–3570. doi: 10.1073/pnas.92.8.3566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kitadai Y., Haruma K., Tokutomi T., Tanaka S., Sumii K., Carvalho M., Kuwabara M., Yoshida K., Hirai T., Kajiyama G. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res. 1998 Sep;4(9):2195–2200. [PubMed] [Google Scholar]
  11. Kukk E., Lymboussaki A., Taira S., Kaipainen A., Jeltsch M., Joukov V., Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. 1996 Dec;122(12):3829–3837. doi: 10.1242/dev.122.12.3829. [DOI] [PubMed] [Google Scholar]
  12. Landgren E., Schiller P., Cao Y., Claesson-Welsh L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene. 1998 Jan 22;16(3):359–367. doi: 10.1038/sj.onc.1201545. [DOI] [PubMed] [Google Scholar]
  13. Newland R. C., Chapuis P. H., Pheils M. T., MacPherson J. G. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer. 1981 Mar 15;47(6):1424–1429. doi: 10.1002/1097-0142(19810315)47:6<1424::aid-cncr2820470630>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  14. Ohta Y., Shridhar V., Bright R. K., Kalemkerian G. P., Du W., Carbone M., Watanabe Y., Pass H. I. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer. 1999 Sep;81(1):54–61. doi: 10.1038/sj.bjc.6690650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Paavonen K., Horelli-Kuitunen N., Chilov D., Kukk E., Pennanen S., Kallioniemi O. P., Pajusola K., Olofsson B., Eriksson U., Joukov V. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation. 1996 Mar 15;93(6):1079–1082. doi: 10.1161/01.cir.93.6.1079. [DOI] [PubMed] [Google Scholar]
  16. Partanen T. A., Alitalo K., Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer. 1999 Dec 1;86(11):2406–2412. [PubMed] [Google Scholar]
  17. Salven P., Lymboussaki A., Heikkilä P., Jäskela-Saari H., Enholm B., Aase K., von Euler G., Eriksson U., Alitalo K., Joensuu H. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol. 1998 Jul;153(1):103–108. doi: 10.1016/S0002-9440(10)65550-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Scheele J., Stangl R., Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990 Nov;77(11):1241–1246. doi: 10.1002/bjs.1800771115. [DOI] [PubMed] [Google Scholar]
  19. Sugihara K., Hojo K., Moriya Y., Yamasaki S., Kosuge T., Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg. 1993 Aug;80(8):1032–1035. doi: 10.1002/bjs.1800800837. [DOI] [PubMed] [Google Scholar]
  20. Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 1996 Apr 15;77(8 Suppl):1722–1728. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1722::AID-CNCR46>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  21. Tsuchiya A., Ando Y., Kikuchi Y., Kanazawa M., Sato H., Abe R. Venous invasion as a prognostic factor in colorectal cancer. Surg Today. 1995;25(11):950–953. doi: 10.1007/BF00312379. [DOI] [PubMed] [Google Scholar]
  22. Tsurusaki T., Kanda S., Sakai H., Kanetake H., Saito Y., Alitalo K., Koji T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer. 1999 Apr;80(1-2):309–313. doi: 10.1038/sj.bjc.6690356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Valtola R., Salven P., Heikkilä P., Taipale J., Joensuu H., Rehn M., Pihlajaniemi T., Weich H., deWaal R., Alitalo K. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol. 1999 May;154(5):1381–1390. doi: 10.1016/S0002-9440(10)65392-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wartiovaara U., Salven P., Mikkola H., Lassila R., Kaukonen J., Joukov V., Orpana A., Ristimäki A., Heikinheimo M., Joensuu H. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost. 1998 Jul;80(1):171–175. [PubMed] [Google Scholar]
  25. Yonemura Y., Endo Y., Fujita H., Fushida S., Ninomiya I., Bandou E., Taniguchi K., Miwa K., Ohoyama S., Sugiyama K. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999 Jul;5(7):1823–1829. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES